Interferon (IFN)- plus bexarotene were effective in the treatment of multi focal, cutaneous, CD30+, large T cell lymphoma

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1324, 2002-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bexarotene in combination with PUVA may be a treatment option in patients with cutaneous T-cell lymphoma refractory to multiple single-agent therapies

By  

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Bexarotene/interferon-α-2b: Extracutaneous tumour mass in a patient with primary cutaneous anaplastic large cell lymphoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1111, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literature

By Quéreux Gaëlle  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 13, 2013-09 ,pp. : 1711-1721

Informa Healthcare

Access to resources Recommend Favorite

Panobinostat is promising for the treatment of patients with cutaneous T-cell lymphoma

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma

By Lansigan Frederick  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 273-286

Adis International

Access to resources Recommend Favorite